Cancer Research Journal » Bile Duct Cancer http://cancerresearchjournal.com Mon, 31 Aug 2009 16:01:16 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 Pro-Pharmaceuticals Reports Progress in Phase II Trials of Biliary Cancer Drug http://cancerresearchjournal.com/2007/07/25/pro-pharmaceuticals-reports-progress-in-phase-ii-trials-of-biliary-cancer-drug/ http://cancerresearchjournal.com/2007/07/25/pro-pharmaceuticals-reports-progress-in-phase-ii-trials-of-biliary-cancer-drug/#comments Wed, 25 Jul 2007 13:11:30 +0000 Lisa http://cancerresearchjournal.com/2007/07/25/pro-pharmaceuticals-reports-progress-in-phase-ii-trials-of-biliary-cancer-drug/ , () is reporting promising preliminary in their of a first-line treatment for .

Participants in the study received the company’s developmental drug, , combined with another common anti-cancer agent, . To date, four of the five patients who have received dosing have stabilized their disease with one patient experiencing 35% shrinkage.

Encouraging results regarding the effectiveness of the DAVANAT, 5-FU treatment combination have already been shown during Phase I and II trials with cancer patients.

The first-line treatment study plans to include up to 42 patients at 6 sites and recruiting is still underway. If you’d like additional information or are interested in participating in the trial, please visit and type in the key word: .

Source:

Related Video: via .

Related stories: ;

Tags: ; ; ; ; ;

]]> http://cancerresearchjournal.com/2007/07/25/pro-pharmaceuticals-reports-progress-in-phase-ii-trials-of-biliary-cancer-drug/feed/ 0